Drug–drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects - Chong, Edward; Kalia, Veena; Willsie, Sandra; Winkle, Peter (Journal of nephrology, 2014)
Keywords: Adult; Angiotensin II Type 1 Receptor Blockers - administration & dosage; Angiotensin II Type 1 Receptor Blockers - adverse effects; Angiotensin II Type 1 Receptor Blockers - blood; Angiotensin II Type 1 Receptor Blockers - pharmacokinetics; Anticoagulants - administration & dosage; Anticoagulants - adverse effects; Anticoagulants - blood; Anticoagulants - pharmacokinetics; Area Under Curve; Cardiotonic Agents - administration & dosage; Cardiotonic Agents - adverse effects; Cardiotonic Agents - blood; Cardiotonic Agents - pharmacokinetics; Chelating Agents - administration & dosage; Chelating Agents - adverse effects; Digoxin - administration & dosage; Digoxin - adverse effects; Digoxin - blood; Digoxin - pharmacokinetics; Diuretics - administration & dosage; Diuretics - adverse effects; Diuretics - blood; Diuretics - pharmacokinetics; Drug Administration Schedule; Drug Combinations; Drug Interactions; Female; Ferric Compounds - administration & dosage; Ferric Compounds - adverse effects; Furosemide - administration & dosage; Furosemide - adverse effects; Furosemide - blood; Furosemide - pharmacokinetics; Half-Life; Healthy Volunteers; Humans; Losartan - administration & dosage; Losartan - adverse effects; Losartan - blood; Losartan - pharmacokinetics; Male; Medicine; Medicine & Public Health; Metabolic Clearance Rate; Middle Aged; Models, Biological; Models, Statistical; Nephrology; Omeprazole - administration & dosage; Omeprazole - adverse effects; Omeprazole - blood; Omeprazole - pharmacokinetics; Original; Original Article; Proton Pump Inhibitors - administration & dosage; Proton Pump Inhibitors - adverse effects; Proton Pump Inhibitors - blood; Proton Pump Inhibitors - pharmacokinetics; Risk Assessment; Sucrose - administration & dosage; Sucrose - adverse effects; Urology; Warfarin - administration & dosage; Warfarin - adverse effects; Warfarin - blood; Warfarin - pharmacokinetics; Young Adult; Hyperphosphatemia; Chronic kidney disease; Phase I; Pharmacokinetics; Sucroferric oxyhydroxide